Cite
HARVARD Citation
Severino, M. et al. (2018). Established amyloid‐β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. Alzheimer's & dementia. 4 (1), pp. 215-223. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Severino, M. et al. (2018). Established amyloid‐β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. Alzheimer's & dementia. 4 (1), pp. 215-223. [Online].